Synopsys Stock’s Upside Now Rests On How It Gets Paid

The chip-design software maker wants to add a royalty on the custom AI chips its biggest customers build, on top of the interface IP license fees it already charges them.

Synopsys (SNPS) makes chip-design software, and also licenses the interface IP that, by management's account, hyperscalers building their own AI accelerators cannot design around. The stock has been marked down anyway: off about 27% over the past twelve months and about 28% below its 52-week high. The upside case that matters is not a faster growth rate but a change in what the company charges the customers it already has, one that starts in the smaller of its two businesses.

Why Management Says A Hyperscaler Cannot Route Around The Interface IP

A company designing its own accelerator is not buying a finished processor but connective tissue: the blocks that let its chip reach memory, a networking part bought elsewhere, and the other dies in its package. By management's own account these chips do not get built without that interface IP, and the design wins have followed. The die-to-die business is on pace to double year over year, with more than 100 cumulative design wins, and Synopsys won more than 95% of PCIe 7 opportunities in fiscal Q3 2026.

The Segment That Turned Is The Smaller One

The larger business is not the problem: design-automation revenue, software and hardware together, grew 8.5% year over year in fiscal Q3 2026, and management has guided it to double-digit organic growth for fiscal 2026. The royalty question sits in the smaller segment. Design IP bottomed in fiscal Q1 2026 and grew 12% sequentially into fiscal Q2 2026. In fiscal Q3 2026, measured year on year, it returned to growth at $474 million, up about 11%.

The segment is under a fifth of the roughly $2.5 billion Synopsys took in for the quarter, so a royalty layer is not a company-wide re-rating by itself. What changes is the shape of the revenue: a royalty rides the volume of chips a customer ships, and by the company's own count design activity is highest among the AI and high-performance compute customers.

Management says it is in advanced discussions with a number of those customers about moving from a license fee to a license plus a royalty. An upside that arrives through a few hyperscaler programs is a different proposition from the Trefis High Quality Portfolio, which does not depend on the handful of largest technology names to produce its returns.

What Has To Land Before The Model Change Counts

Nothing has been signed publicly. Management has promised to lay out the new model on September 30, 2026. Multiphysics Fusion, the first product built out of the Ansys deal, does not begin adding to design-automation growth until 2027. The thing to watch is not the direction of the IP line, which management has already guided higher for fiscal Q4 2026, but whether a signed royalty agreement gets named beside it.

The upside is scheduled rather than delivered, a fair reason for the stock to sit where it does and a poor reason to assume it stays there. Synopsys has cleared more than 30% inside two months on seven separate occasions, the earliest of those gains in 2019 and the most recent in 2025. But whether that record makes this particular decline one to buy is exactly what a dip-buyer's screen exists to answer.

A Repricing Story Is Still One Company's Story

A change in how a company gets paid can compound for years, and it can also stall for reasons that have nothing to do with the technology. Holding that kind of upside inside a system rather than a single position is the argument for the Trefis High Quality Portfolio. That portfolio has a track record of outpacing the three major indices - the S&P 500, S&P Mid-cap, and Russell 2000.